We are live on ! Find out more
TGA

TPG GP A Portfolio holdings

AUM $3.68B
1-Year Est. Return 14.99%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+14.99%
3 Year Est. Return
+76.26%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.43B
AUM Growth
+$1.2B
Cap. Flow
+$1.13B
Cap. Flow %
17.59%
Top 10 Hldgs %
78.44%
Holding
42
New
8
Increased
2
Reduced
15
Closed
8

Top Buys

Rank Stock Value
1
VIK icon
Viking Holdings
VIK
+$1.83B
2
PGNY icon
Progyny
PGNY
+$199M
3
NXT icon
Nextpower Inc
NXT
+$149M
4
LW icon
Lamb Weston
LW
+$106M
5
HDB icon
HDFC Bank
HDB
+$87.1M

Top Sells

Rank Stock Value
1
CWK icon
Cushman & Wakefield Ltd
CWK
+$179M
2
EDR
Endeavor Group Holdings, Inc.
EDR
+$123M
3
HCP
HashiCorp, Inc. Class A Common Stock
HCP
+$101M
4
LFST icon
Lifestance Health
LFST
+$87.9M
5
UNF icon
Unifirst Corp
UNF
+$58.1M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 50.37%
2 Healthcare 22.39%
3 Technology 10.41%
4 Communication Services 4.55%
5 Consumer Staples 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FWONA icon
26
Liberty Media Series A
FWONA
$22.8B
$44.5M 0.69%
693,452
-21,833
-3% -$1.39M
ALLO icon
27
Allogene Therapeutics
ALLO
$639M
$43.6M 0.68%
18,716,306
– –
AMT icon
28
American Tower
AMT
$77.8B
$31.9M 0.5%
+164,308
New +$30.7M
NRDY icon
29
Nerdy
NRDY
$105M
$17.7M 0.28%
10,595,472
– –
FERG icon
30
Ferguson
FERG
$44.4B
$11.5M 0.18%
59,571
-95,259
-62% -$20M
RLYB icon
31
Rallybio
RLYB
$89.7M
$4.06M 0.06%
378,552
– –
CARM
32
DELISTED
Carisma Therapeutics
CARM
$1.28M 0.02%
842,031
-609,850
-42% -$910K
VCSA
33
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$1.04M 0.02%
213,792
– –
UXIN
34
Uxin Ltd
UXIN
$335M
$198K ﹤0.01%
95,945
– –
OPTU
35
Optimum Communications Inc
OPTU
$352M
– –
-6,596,818
Closed -$17.2M
CWK icon
36
Cushman & Wakefield Ltd
CWK
$3.06B
– –
-17,098,001
Closed -$179M
UNF icon
37
Unifirst Corp
UNF
$5.24B
– –
-335,109
Closed -$58.1M
EDR
38
DELISTED
Endeavor Group Holdings, Inc.
EDR
– –
-4,762,811
Closed -$123M
HCP
39
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
– –
-3,750,018
Closed -$101M
FUSN
40
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
– –
-2,551,794
Closed -$54.4M
1
2

Similar funds

SLG
Silver Lake Group Menlo Park, California $3.68B AUM 7.22% 1-Year Est. Return
EPIM
Evelyn Partners Investment Management London $3.68B AUM 21.15% 1-Year Est. Return
HIM
Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return
BB
Busey Bank Urbana, Illinois $3.68B AUM 26.6% 1-Year Est. Return
MTIM
Marathon Trading Investment Management Radnor, Pennsylvania $3.67B AUM 21.97% 1-Year Est. Return
CAM
Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return
MMA
Mizuho Markets Americas New York $3.66B AUM 25.21% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return

TPG GP A's Q2 2024 Portfolio in Review

As of Q2 2024, TPG GP A held 42 positions worth $6.43B, up 23% from $5.22B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

TPG GP A deployed $1.13B of net new capital in Q2 2024, opening 8 new positions and adding to 2 existing holdings. Its largest new stake was Viking Holdings: 60,809,642 shares worth $2.06B.

By sector, the portfolio is most concentrated in Consumer Discretionary at 50% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Lifestance Health, an estimated $87.9M trimmed.

  • TPG GP A's largest Q2 2024 buy was Viking Holdings: 60,809,642 shares worth $2.06B.
  • TPG GP A added most to Lamb Weston in Q2 2024, an estimated $106M increase.
  • TPG GP A's biggest Q2 2024 reduction was Lifestance Health, cutting an estimated $87.9M.
  • TPG GP A fully exited Cushman & Wakefield Ltd in Q2 2024, selling an estimated $179M.
  • TPG GP A's ten largest holdings make up 78% of its $6.43B portfolio in Q2 2024.
  • TPG GP A opened 8 new positions and closed 8 in Q2 2024.
  • TPG GP A's portfolio value rose 23% quarter-over-quarter to $6.43B.

Based on TPG GP A's 13F filing for Q2 2024, filed 14 Aug 2024.